Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Schwartz, TW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 69 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fraile-Ramos, A; Kledal, TN; Pelchen-Matthews, A; Bowers, K; Schwartz, TW; Marsh, M
      The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling

      MOLECULAR BIOLOGY OF THE CELL
    2. Rosenkilde, MM; Waldhoer, M; Luttichau, HR; Schwartz, TW
      Virally encoded 7TM receptors

      ONCOGENE
    3. Luttichau, HR; Gerstoft, J; Schwartz, TW
      MC148 encoded by human molluscum contagiosum poxvirus is an antagonist forhuman but not murine CCR8

      JOURNAL OF LEUKOCYTE BIOLOGY
    4. Schwartz, TW; Verlaege, O
      The first PP supper - Camelot at Bispebjerg

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    5. Hatse, S; Princen, K; Gerlach, LO; Bridger, G; Henson, G; De Clercq, E; Schwartz, TW; Schols, D
      Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100

      MOLECULAR PHARMACOLOGY
    6. Mizoue, LS; Sullivan, SK; King, DS; Kledal, TN; Schwartz, TW; Bacon, KB; Handel, TM
      Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Holst, B; Hastrup, H; Raffetseder, U; Martini, L; Schwartz, TW
      Two active molecular phenotypes of the tachykinin NK1 receptor revealed byG-protein fusions and mutagenesis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    8. Gerlach, LO; Skerlj, RT; Bridger, GJ; Schwartz, TW
      Molecular interactions of cyclam and bicyclam non-peptide antagonists withthe CXCR4 chemokine receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Luttichau, HR; Lewis, IC; Gerstoft, J; Schwartz, TW
      The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor

      EUROPEAN JOURNAL OF IMMUNOLOGY
    10. Jensen, KK; Martini, L; Schwartz, TW
      Enhanced fluorescence resonance energy transfer between spectral variants of green fluorescent protein through zinc-site engineering

      BIOCHEMISTRY
    11. Holst, B; Elling, CE; Schwartz, TW
      Partial agonism through a zinc-ion switch constructed between transmembrane domains III and VII in the tachykinin NK1 receptor

      MOLECULAR PHARMACOLOGY
    12. Rosenkilde, MM; Schwartz, TW
      Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor

      MOLECULAR PHARMACOLOGY
    13. Larson, DL; Jones, RM; Hjorth, SA; Schwartz, TW; Portoghese, PS
      Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: Molecular recognition loci for the pharmacophore and address components of kappa antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    14. Luttichau, HR; Stine, J; Boesen, TP; Johnsen, AH; Chantry, D; Gerstoft, J; Schwartz, TW
      A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum

      JOURNAL OF EXPERIMENTAL MEDICINE
    15. Rosenkilde, MM; Kledal, TN; Holst, PJ; Schwartz, TW
      Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74

      JOURNAL OF BIOLOGICAL CHEMISTRY
    16. Costa-Neto, CM; Mikakawa, AA; Oliveira, L; Hjorth, SA; Schwartz, TW; Paiva, ACM
      Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT(1A) receptor

      BRITISH JOURNAL OF PHARMACOLOGY
    17. Elling, CE; Raffetseder, U; Nielsen, SM; Schwartz, TW
      Disulfide bridge engineering in the tachykinin NK1 receptor

      BIOCHEMISTRY
    18. Elling, CE; Thirstrup, K; Holst, B; Schwartz, TW
      Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    19. Klasse, PJ; Rosenkilde, MM; Signoret, N; Pelchen-Matthews, A; Schwartz, TW; Marsh, M
      CD4-chemokine receptor hybrids in human immunodeficiency virus type 1 infection

      JOURNAL OF VIROLOGY
    20. Rosenkilde, MM; Kledal, TN; Brauner-Osborne, H; Schwartz, TW
      Agonists and inverse agonists for the herpesvirus 8-encoded constitutivelyactive seven-transmembrane oncogene product, ORF-74

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. HJORTH SA; ORSKOV C; SCHWARTZ TW
      CONSTITUTIVE ACTIVITY OF GLUCAGON RECEPTOR MUTANTS

      Molecular endocrinology
    22. DITZEL HJ; ROSENKILDE MM; GARRED P; WANG M; KOEFOED K; PEDERSEN C; BURTON DR; SCHWARTZ TW
      THE CCR5 RECEPTOR ACTS AS AN ALLOANTIGEN IN CCR5-DELTA-32 HOMOZYGOUS INDIVIDUALS - IDENTIFICATION OF CHEMOKINE-BLOCKING AND HIV-1-BLOCKING HUMAN-ANTIBODIES

      Proceedings of the National Academy of Sciences of the United Statesof America
    23. HOLST B; ZOFFMANN S; ELLING CE; HJORTH SA; SCHWARTZ TW
      STERIC HINDRANCE MUTAGENESIS VERSUS ALANINE SCAN IN MAPPING OF LIGAND-BINDING SITES IN THE TACHYKININ NK1 RECEPTOR

      Molecular pharmacology
    24. Jones, RM; Hjorth, SA; Schwartz, TW; Portoghese, PS
      Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors

      JOURNAL OF MEDICINAL CHEMISTRY
    25. SIGNORET N; ROSENKILDE MM; KLASSE PJ; SCHWARTZ TW; MALIM MH; HOXIE JA; MARSH M
      DIFFERENTIAL REGULATION OF CXCR4 AND CCR5 ENDOCYTOSIS

      Journal of Cell Science
    26. ROSENKILDE MM; LUCIBELLO M; HOLST B; SCHWARTZ TW
      NATURAL AGONIST ENHANCING BIS-HIS ZINC-SITE IN TRANSMEMBRANE SEGMENT-V OF THE TACHYKININ NK3 RECEPTOR

      FEBS letters
    27. Kledal, TN; Rosenkilde, MM; Schwartz, TW
      Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28

      FEBS LETTERS
    28. NIELSEN SM; ELLING CE; SCHWARTZ TW
      SPLIT-RECEPTORS IN THE TACHYKININ NEUROKININ-1 SYSTEM - MUTATIONAL ANALYSIS OF INTRACELLULAR LOOP-3

      European journal of biochemistry
    29. ELLING CE; THIRSTRUP K; NIELSEN SM; HJORTH SA; SCHWARTZ TW
      ENGINEERING OF METAL-ION SITES AS DISTANCE CONSTRAINTS IN STRUCTURAL AND FUNCTIONAL-ANALYSIS OF 7TM RECEPTORS

      Folding & design
    30. WELLS TNC; SCHWARTZ TW
      PLAGIARISM OF THE HOST IMMUNE-SYSTEM - LESSONS ABOUT CHEMOKINE IMMUNOLOGY FROM VIRUSES

      Current opinion in biotechnology
    31. KLEDAL TN; ROSENKILDE MM; COULIN F; SIMMONS G; JOHNSEN AH; ALOUANI S; POWER CA; LUTTICHAU HR; GERSTOFT J; CLAPHAM PR; CLARKLEWIS I; WELLS TNC; SCHWARTZ TW
      A BROAD-SPECTRUM CHEMOKINE ANTAGONIST ENCODED BY KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS

      Science
    32. SIMMONS G; CLAPHAM PR; PICARD L; OFFORD RE; ROSENKILDE MM; SCHWARTZ TW; BUSER R; WELLS TNC; PROUDFOOT AEI
      POTENT INHIBITION OF HIV-1 INFECTIVITY IN MACROPHAGES AND LYMPHOCYTESBY A NOVEL CCR5 ANTAGONIST

      Science
    33. PERLMAN S; COSTANETO CM; MIYAKAWA AA; SCHAMBYE HT; HJORTH SA; PAIVA ACM; RIVERO RA; GREENLEE WJ; SCHWARTZ TW
      DUAL AGONISTIC AND ANTAGONISTIC PROPERTY OF NONPEPTIDE ANGIOTENSIN AT(1) LIGANDS - SUSCEPTIBILITY TO RECEPTOR MUTATIONS

      Molecular pharmacology
    34. SIGNORET N; OLDRIDGE J; PELCHENMATTHEWS A; KLASSE PJ; TRAN T; BRASS LF; ROSENKILDE MM; SCHWARTZ TW; HOLMES W; DALLAS W; LUTHER MA; WELLS TNC; HOXIE JA; MARSH M
      PHORBOL ESTERS AND SDF-1 INDUCE RAPID ENDOCYTOSIS AND DOWN-MODULATIONOF THE CHEMOKINE RECEPTOR CXCR4

      The Journal of cell biology
    35. TURCATTI G; ZOFFMANN S; LOWE JA; DROZDA SE; CHASSAING G; SCHWARTZ TW; CHOLLET A
      CHARACTERIZATION OF NONPEPTIDE ANTAGONIST AND PEPTIDE AGONIST BINDING-SITES OF THE NK1 RECEPTOR WITH FLUORESCENT LIGANDS

      The Journal of biological chemistry
    36. MAGGI CA; SCHWARTZ TW
      THE DUAL NATURE OF THE TACHYKININ NK1 RECEPTOR

      Trends in pharmacological sciences
    37. ELLING CE; SCHWARTZ TW
      CONNECTIVITY AND ORIENTATION OF THE 7 HELICAL BUNDLE IN THE TACHYKININ NK-1 RECEPTOR PROBED BY ZINC SITE ENGINEERING

      EMBO journal
    38. OHARE MMT; SCHWARTZ TW
      BIOSYNTHESIS OF NEUROPEPTIDE-Y IN PORCINE TISSUES AND GENERATION OF N-TERMINAL FRAGMENTS IN NEUROBLASTOMA CELL-LINES

      Peptides
    39. HJORTH SA; THIRSTRUP K; SCHWARTZ TW
      RADIOLIGAND-DEPENDENT DISCREPANCY IN AGONIST AFFINITIES ENHANCED BY MUTATIONS IN THE KAPPA-OPIOID RECEPTOR

      Molecular pharmacology
    40. THIRSTRUP K; ELLING CE; HJORTH SA; SCHWARTZ TW
      CONSTRUCTION OF A HIGH-AFFINITY ZINC SWITCH IN THE KAPPA-OPIOID RECEPTOR

      The Journal of biological chemistry
    41. HASTRUP H; SCHWARTZ TW
      SEPTIDE AND NEUROKININ-A ARE HIGH-AFFINITY LIGANDS ON THE NK-1 RECEPTOR - EVIDENCE FROM HOMOLOGOUS VERSUS HETEROLOGOUS BINDING ANALYSIS

      FEBS letters
    42. HJORTH SA; SCHWARTZ TW
      GLUCAGON AND GLP-1 RECEPTORS - LESSONS FROM CHIMERIC LIGANDS AND RECEPTORS

      Acta Physiologica Scandinavica
    43. SCHWARTZ TW; ROSENKILDE MM
      IS THERE A LOCK FOR ALL AGONIST KEYS IN 7TM RECEPTORS

      Trends in pharmacological sciences
    44. SCHWARTZ TW; ROSENKILDE MM
      7TM RECEPTORS - LOCKS AND KEYS - REPLY

      Trends in pharmacological sciences
    45. GETHER U; LOWE JA; SCHWARTZ TW
      TACHYKININ NONPEPTIDE ANTAGONISTS - BINDING DOMAIN AND MOLECULAR-MODEOF ACTION

      Biochemical Society transactions
    46. ELLING CE; NIELSEN SM; SCHWARTZ TW
      CONVERSION OF ANTAGONIST-BINDING SITE TO METAL-ION SITE IN THE TACHYKININ NK-1 RECEPTOR

      Nature
    47. HJORTH SA; THIRSTRUP K; GRANDY DK; SCHWARTZ TW
      ANALYSIS OF SELECTIVE BINDING EPITOPES FOR THE KAPPA-OPIOID RECEPTOR ANTAGONIST NOR-BINALTORPHIMINE

      Molecular pharmacology
    48. SCHAMBYE HT; HJORTH SA; WEINSTOCK J; SCHWARTZ TW
      INTERACTION BETWEEN THE NONPEPTIDE ANGIOTENSIN ANTAGONIST SKF-108,566AND HISTIDINE-256 (HISVI-16) OF THE ANGIOTENSIN TYPE-1 RECEPTOR

      Molecular pharmacology
    49. PERLMAN S; SCHAMBYE HT; RIVERO RA; GREENLEE WJ; HJORTH SA; SCHWARTZ TW
      NONPEPTIDE ANGIOTENSIN AGONIST - FUNCTIONAL AND MOLECULAR INTERACTIONWITH THE AT(1) RECEPTOR

      The Journal of biological chemistry
    50. SCHWARTZ TW; HJORTH SA; ELLING C; NIELSEN SM; GETHER U; ROSENKILDE MM; ZOFFMANN S; DENHOLLANDER R; SCHAMBYE HT; PERLMANN S; VANVIJK B
      MOLECULAR MECHANISM OF ACTIVATION AND INHIBITION OF 7TM PEPTIDE RECEPTORS

      European journal of pharmaceutical sciences
    51. HAGLUND MM; OJEMANN GA; SCHWARTZ TW; LETTICH E
      NEURONAL-ACTIVITY IN HUMAN LATERAL TEMPORAL CORTEX DURING SERIAL RETRIEVAL FROM SHORT-TERM-MEMORY

      The Journal of neuroscience
    52. COX HM; SCHWARTZ TW
      FUNCTIONAL EXPRESSION OF Y-1 RECEPTORS TRANSFECTED INTO HUMAN EPITHELIA IN CULTURE

      Regulatory peptides
    53. SCHAMBYE HT; HJORTH SA; BERGSMA DJ; SATHE G; SCHWARTZ TW
      DIFFERENTIATION BETWEEN BINDING-SITES FOR ANGIOTENSIN-II AND NONPEPTIDE ANTAGONISTS ON THE ANGIOTENSIN-II TYPE-1 RECEPTORS

      Proceedings of the National Academy of Sciences of the United Statesof America
    54. GETHER U; EMONDSALT X; BRELIERE JC; FUJII T; HAGIWARA D; PRADIER L; GARRET C; JOHANSEN TE; SCHWARTZ TW
      EVIDENCE FOR A COMMON MOLECULAR-MODE OF ACTION FOR CHEMICALLY DISTINCT NONPEPTIDE ANTAGONISTS AT THE NEUROKININ-1 (SUBSTANCE-P) RECEPTOR

      Molecular pharmacology
    55. JENSEN CJ; GERARD NP; SCHWARTZ TW; GETHER U
      THE SPECIES SELECTIVITY OF CHEMICALLY DISTINCT TACHYKININ NONPEPTIDE ANTAGONISTS IS DEPENDENT ON COMMON DIVERGENT RESIDUES OF THE RAT AND HUMAN NEUROKININ-1 RECEPTORS

      Molecular pharmacology
    56. GETHER U; NILSSON L; LOWE JA; SCHWARTZ TW
      SPECIFIC RESIDUES AT THE TOP OF TRANSMEMBRANE SEGMENT-V AND SEGMENT-VI OF THE NEUROKININ-1 RECEPTOR INVOLVED IN BINDING OF THE NONPEPTIDE ANTAGONIST CP 96,345. (VOL 269, PG 23959, 1994)

      The Journal of biological chemistry
    57. HJORTH SA; SCHAMBYE HT; GREENLEE WJ; SCHWARTZ TW
      IDENTIFICATION OF PEPTIDE BINDING RESIDUES IN THE EXTRACELLULAR DOMAINS OF THE AT(1) RECEPTOR

      The Journal of biological chemistry
    58. HJORTH SA; ADELHORST K; PEDERSEN BB; KIRK O; SCHWARTZ TW
      GLUCAGON AND GLUCAGON-LIKE PEPTIDE-1 - SELECTIVE RECEPTOR RECOGNITIONVIA DISTINCT PEPTIDE EPITOPES

      The Journal of biological chemistry
    59. ROSENKILDE MM; CAHIR M; GETHER U; HJORTH SA; SCHWARTZ TW
      MUTATIONS ALONG TRANSMEMBRANE SEGMENT-II OF THE NK-1 RECEPTOR AFFECT SUBSTANCE-P COMPETITION WITH NONPEPTIDE ANTAGONISTS BUT NOT SUBSTANCE-P BINDING

      The Journal of biological chemistry
    60. GETHER U; NILSSON L; LOWE JA; SCHWARTZ TW
      SPECIFIC RESIDUES AT THE TOP OF TRANSMEMBRANE SEGMENT-V AND SEGMENT-VI OF THE NEUROKININ-1 RECEPTOR INVOLVED IN BINDING OF THE NONPEPTIDE ANTAGONIST CP-96,345

      The Journal of biological chemistry
    61. SCHAMBYE HT; VONWIJK B; HJORTH SA; WIENEN W; ENTZEROTH M; BERGSMA DJ; SCHWARTZ TW
      MUTATIONS IN TRANSMEMBRANE SEGMENT-VII OF THE AT(1) RECEPTOR DIFFERENTIATE BETWEEN CLOSELY-RELATED INSURMOUNTABLE AND COMPETITIVE ANGIOTENSIN ANTAGONISTS

      British Journal of Pharmacology
    62. LARSEN PJ; SHEIKH SP; JAKOBSEN CR; SCHWARTZ TW; MIKKELSEN JD
      REGIONAL DISTRIBUTION OF PUTATIVE NPY Y(1) RECEPTORS AND NEURONS EXPRESSING Y(1) MESSENGER-RNA IN FOREBRAIN AREAS OF THE RAT CENTRAL-NERVOUS-SYSTEM

      European journal of neuroscience
    63. NAKAGAWA SH; JOHANSEN NL; MADSEN K; SCHWARTZ TW; TAGER HS
      IMPLICATIONS OF REPLACING PEPTIDE-BONDS IN THE COOH-TERMINAL-B CHAIN DOMAIN OF INSULIN BY THE PSI(CH2-NH) LINKER

      International journal of peptide & protein research
    64. GETHER U; JOHANSEN TE; SNIDER RM; LOWE JA; EMONDSALT X; YOKOTA Y; NAKANISHI S; SCHWARTZ TW
      BINDING EPITOPES FOR PEPTIDE AND NONPEPTIDE LIGANDS ON THE NK1 (SUBSTANCE-P) RECEPTOR

      Regulatory peptides
    65. GETHER U; YOKOTA Y; EMONDSALT X; BRELIERE JC; LOWE JA; SNIDER RM; NAKANISHI S; SCHWARTZ TW
      2 NONPEPTIDE TACHYKININ ANTAGONISTS ACT THROUGH EPITOPES ON CORRESPONDING SEGMENTS OF THE NK1 AND NK2 RECEPTORS

      Proceedings of the National Academy of Sciences of the United Statesof America
    66. GETHER U; JOHANSEN TE; SNIDER RM; LOWE JA; YOKOTA Y; EMONDSALT X; BRELIERE J; NAKANISHI S; SCHWARTZ TW
      IDENTIFICATION OF BINDING EPITOPES FOR NONPEPTIDE ANTAGONISTS ON THE TACHYKININ RECEPTORS THROUGH CONSTRUCTION OF CHIMERIC NK-1 NK-2 AND NK-1/NK-3 RECEPTORS/

      Journal of neurochemistry
    67. WULFF BS; JOHANSEN TE; DALBOGE H; OHARE MMT; SCHWARTZ TW
      PROCESSING OF 2 HOMOLOGOUS PRECURSORS, PRO-NEUROPEPTIDE-Y AND PRO-PANCREATIC POLYPEPTIDE, IN TRANSFECTED CELL-LINES EXPRESSING DIFFERENT PRECURSOR CONVERTASES

      The Journal of biological chemistry
    68. ZOFFMANN S; GETHER U; SCHWARTZ TW
      CONSERVED HIS(VI-17) OF THE NK-1 RECEPTOR IS INVOLVED IN BINDING OF NONPEPTIDE ANTAGONISTS BUT NOT SUBSTANCE-P

      FEBS letters
    69. SCHAMBYE HT; HJORTH SA; BERGSMA DJ; SCHWARTZ TW
      BINDING EPITOPES FOR NONPEPTIDE ANTAGONISTS ON THE ANGIOTENSIN AT(1)-RECEPTOR

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 00:32:10